HIGHFDA DRUG

Teva Metoprolol Succinate ER 100 mg Recall Expanded for Failed Dissolution Specifications (2026)

Teva Pharmaceuticals recalled 7,448 bottles of Metoprolol Succinate Extended-Release Tablets nationwide after failed dissolution specifications were identified. The recall involves 100 mg, 100‑tablet bottles (NDC 45963-677-11) and 1,000‑tablet bottles (NDC 45963-677-96). The defect may affect drug release and efficacy. Patients should stop using affected bottles and contact Teva or their clinician

Official notice

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DRUG
Recall date
January 29, 2026
Status
ACTIVE
Severity
8/10

Quick Facts at a Glance

Recall Date
January 29, 2026
Hazard Level
HIGH
Brands
METOPROLOL SUCCINATE, Actavis Pharma
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Drug Safety; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
METOPROLOL SUCCINATE, Actavis Pharma
Product type
Prescription beta-blocker (Metoprolol Succinate ER)
Model numbers
0718J251, 0729J251, 0730J251, 0718J252, 0729J252, 0730J252
UPC codes
45963-676, 45963-709, 45963-677, 45963-678, 45963-709-11, 45963-709-96, 45963-676-11, 45963-676-96 +3 more
Sizes
100 mg, 1000 tablet bottles
Sold at
Multiple Retailers
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    January 29, 2026

  2. Reported by FDA DRUG

    March 11, 2026

  3. RecallRadar source check

    March 18, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

Failed Dissolution Specifications

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact Teva Pharmaceuticals USA, Inc or your healthcare provider for guidance. Notification method: Letter

About This Product

Metoprolol Succinate is a beta-blocker used to treat high blood pressure and heart-related conditions. It is sold as an extended-release tablet by Teva and other manufacturers as a prescription medicine.

Why This Is Dangerous

Dissolution failures can lead to inconsistent or insufficient drug release, potentially reducing efficacy or causing fluctuating drug levels in patients.

Industry Context

This recall is not described as part of a broader industry pattern.

Real-World Impact

Patients taking affected lots may experience reduced blood pressure control or inconsistent therapeutic effects. There is no mention of acute injuries in the recall notice.

Practical Guidance

How to identify if yours is affected

  1. Verify NDC 45963-677-11 or 45963-677-96 on bottle label.
  2. Confirm distributed nationwide and Rx-only status.

Where to find product info

Recall details available at FDA enforcement report D-0356-2026 and Teva’s recall communications.

What timeline to expect

Refund or replacement timelines are not specified. Coordinate with your pharmacy and clinician.

If the manufacturer is unresponsive

  • Ask your pharmacist to escalate the issue to the prescribing clinician.
  • File a report with FDA MedWatch if drug safety concerns persist.

How to prevent similar issues

  • Always verify NDCs and lot numbers when receiving prescription medications.
  • Keep all recall notices and pharmacy receipts for reference.
  • Consult your clinician before stopping or changing any prescribed therapy.

Documentation advice

Keep bottle and recall notice, take photos of the label, retain serial codes and correspondence with Teva or the pharmacy.

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

NDCs: 45963-677-11 (100 mg, 100-tablet bottles) and 45963-677-96 (1000-tablet bottles). Distribution: Nationwide. Quantity: 7,448 bottles. Sold as Rx Only. Brand: METOPROLOL SUCCINATE. Manufacturer: Teva Pharmaceuticals USA, Parsippany, NJ 07054.

Key Facts

  • 7,448 bottles recalled nationwide
  • Hazard: Failed dissolution specifications
  • Remedy: Stop use and contact Teva or healthcare provider

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Classification

Product Details

Model Numbers
0718J251
0729J251
0730J251
0718J252
0729J252
+1 more
UPC Codes
45963-676
45963-709
45963-677
+8 more
Affected States
ALL
Report Date
March 11, 2026
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE